STERIGENICS DENMARK A/S: Financial statements 2012
CVR: 26299691
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
STERIGENICS DENMARK A/S (CVR 26299691) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 13,408,921 and a net result of DKK 2,874,221. Equity in the 2012 report amounted to DKK 19,422,507. The solvency ratio was 33.8%.
- Gross Profit
- DKK 13,408,921
- Profit/Loss
- DKK 2,874,221
- Equity
- DKK 19,422,507
- Total Assets
- DKK 57,536,926
Official annual report
Keep an eye on STERIGENICS DENMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 24, 2012, JUT NR. 2180 A/S has been appointed auditor of STERIGENICS DENMARK A/S.
As of January 24, 2012, JUT NR. 2180 A/S has stepped down as auditor of STERIGENICS DENMARK A/S.
As of January 19, 2012, Eric Meyers has joined the board of directors of STERIGENICS DENMARK A/S.
As of January 19, 2012, Sylvie Schottey has joined the board of directors of STERIGENICS DENMARK A/S.
As of January 19, 2012, Marc Markey has left the board of directors of STERIGENICS DENMARK A/S.
As of January 19, 2012, Eddy Caspers has left the board of directors of STERIGENICS DENMARK A/S.
About STERIGENICS DENMARK A/S
STERIGENICS DENMARK A/S is a Danish company of the type Aktieselskab based in Espergærde, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IBA S&I (DENMARK) A/S. The management consists of Maja Nøddekær. The board consists of Robin Van Der Bergh (chair), Maja Nøddekær and Ronald Victor Asselberghs. The company is owned by Nelson Labs BV. The company has 51 employees (2026). In 2025, the company reported a gross profit of DKK 45,023,268 and a net result of DKK 24,334,784 compared with DKK 25,507,602 the year before. Equity in the 2025 report amounted to DKK 44,335,784.